Xue Feng Zhang
Overview
Explore the profile of Xue Feng Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang Y, Shao S, Li X, Zhao Z, Liu N, Liu Z, et al.
Science
. 2024 Sep;
385(6716):1484-1491.
PMID: 39325881
The respiratory syncytial virus (RSV) fusion (F) glycoprotein is highly immunogenic in its prefusion (pre-F) conformation. However, the protein is unstable, and its conformation must be stabilized for it to...
2.
Shao S, Zhang X, Hou J, Yang S, Han Z, Wu H, et al.
NPJ Vaccines
. 2024 Mar;
9(1):62.
PMID: 38503757
Respiratory syncytial virus (RSV) is one of the most important pathogens causing respiratory tract infection in humans, especially in infants and the elderly. The identification and structural resolution of the...
3.
Hou Y, Jin Y, Zhang X, Tang F, Hou J, Liu Z, et al.
J Virol
. 2023 Oct;
97(10):e0093823.
PMID: 37792003
Human norovirus (HuNoV) is highly infectious and can result in severe illnesses in the elderly and children. So far, there is no effective antiviral drug to treat HuNoV infection, and...
4.
Wang W, Ma Y, Lei Z, Zhang X, Li J, Li S, et al.
J Mol Graph Model
. 2023 Jun;
124:108540.
PMID: 37352723
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised concerns worldwide due to its enhanced transmissibility and immune escapability. The first dominant Omicron BA.1 subvariant harbors...
5.
Al Kaabi N, Yang Y, Liang Y, Xu K, Zhang X, Kang Y, et al.
Signal Transduct Target Ther
. 2023 Jan;
8(1):20.
PMID: 36596779
An ongoing randomized, double-blind, controlled phase 2 trial was conducted to evaluate the safety and immunogenicity of a mosaic-type recombinant vaccine candidate, named NVSI-06-09, as a booster dose in subjects...
6.
Zhang J, Han Z, Liang Y, Zhang X, Jin Y, Du L, et al.
Elife
. 2022 Aug;
11.
PMID: 36004719
Large-scale populations in the world have been vaccinated with COVID-19 vaccines, however, breakthrough infections of SARS-CoV-2 are still growing rapidly due to the emergence of immune-evasive variants, especially Omicron. It...
7.
Chen X, Dong J, Rong J, Xiao J, Zhao W, Aschalew N, et al.
Trop Anim Health Prod
. 2022 Apr;
54(3):159.
PMID: 35419715
This study aimed to access the effect of heat stress on milk yield, antioxidative levels, and serum metabolites in primiparous and multiparous Holstein dairy cows during the early lactation stage....
8.
Liang Y, Zhang J, Yuan R, Wang M, He P, Su J, et al.
Cell Discov
. 2022 Feb;
8(1):17.
PMID: 35169113
The continuous emergence of SARS-CoV-2 variants highlights the need of developing vaccines with broad protection. Here, according to the immune-escape capability and evolutionary convergence, the representative SARS-CoV-2 strains carrying the...
9.
Liang Y, Wang W, Zhang J, Hou J, Tang F, Zhang X, et al.
PLoS Pathog
. 2021 Jul;
17(7):e1009745.
PMID: 34252166
Norovirus (NoV) is the major pathogen causing the outbreaks of the viral gastroenteritis across the world. Among the various genotypes of NoV, GII.4 is the most predominant over the past...
10.
Zhao W, Chen X, Xiao J, Chen X, Zhang X, Wang T, et al.
Asian-Australas J Anim Sci
. 2019 Apr;
32(12):1889-1896.
PMID: 31010972
Objective: This study aimed to investigate the effects of prepartum body condition score (BCS) on the milk yield, lipid metabolism, and oxidative status of Holstein cows. Methods: A total of...